COVID variables in R&D;Number of employees;Total
Number of enterprises that carry out intramural R&D;Less than 10 employees;2.752
Number of enterprises that carry out intramural R&D;From 10 to 49 employees;4.509
Number of enterprises that carry out intramural R&D;From 50 to 249 employees;2.862
Number of enterprises that carry out intramural R&D;250 and more employees;1.065
Number of enterprises that carry out intramural R&D;Total;11.188
% of companies whose internal R&D expenditure was increased by COVID-19;Less than 10 employees;7,98
% of companies whose internal R&D expenditure was increased by COVID-19;From 10 to 49 employees;7,31
% of companies whose internal R&D expenditure was increased by COVID-19;From 50 to 249 employees;5,51
% of companies whose internal R&D expenditure was increased by COVID-19;250 and more employees;5,67
% of companies whose internal R&D expenditure was increased by COVID-19;Total;6,86
% of companies whose internal R&D expenditure was decreased by COVID-19;Less than 10 employees;30,45
% of companies whose internal R&D expenditure was decreased by COVID-19;From 10 to 49 employees;27,2
% of companies whose internal R&D expenditure was decreased by COVID-19;From 50 to 249 employees;26,2
% of companies whose internal R&D expenditure was decreased by COVID-19;250 and more employees;29,33
% of companies whose internal R&D expenditure was decreased by COVID-19;Total;27,95
% of companies that performed internal R&D related to COVID-19;Less than 10 employees;7,96
% of companies that performed internal R&D related to COVID-19;From 10 to 49 employees;8,25
% of companies that performed internal R&D related to COVID-19;From 50 to 249 employees;8,25
% of companies that performed internal R&D related to COVID-19;250 and more employees;11,01
% of companies that performed internal R&D related to COVID-19;Total;8,44
Total expenditure on internal R&D related to COVID-19;Less than 10 employees;8.106
Total expenditure on internal R&D related to COVID-19;From 10 to 49 employees;23.155
Total expenditure on internal R&D related to COVID-19;From 50 to 249 employees;39.162
Total expenditure on internal R&D related to COVID-19;250 and more employees;58.852
Total expenditure on internal R&D related to COVID-19;Total;129.275